ArticleToxicology reports2019

Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3.

Laura Tornatore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.